Clinical Trials Insight: 700057631
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2010
At a glance
- Drugs ADX 71149 (Primary)
- Indications Anxiety
- Focus Therapeutic Use
- Sponsors Addex Therapeutics
- 25 Aug 2010 Now the phase I programme is complete, enrollment is expected to begin in the first quarter of 2011, according to an Addex Pharmaceuticals media release.
- 13 Jul 2010 A phase II study of ADX 71149 is expected to start in 2010, according to an Addex Pharmaceuticals media release.
- 13 Jul 2010 New trial record